入局、研修のご案内

業 績


  ■ 2000年   ■ 2001年   ■ 2002年   ■ 2003年   ■ 2004年   ■ 2005年   ■ 2006年   ■ 2007年
  ■ 2008年   ■ 2009年   ■ 2010年   ■ 2011年   ■ 2012年   ■ 2013年   ■ 2014年   ■ 2015年
  ■ 2016年   ■ 2017年   ■ 2018年   ■ 2019年   ■ 2020年   ■ 2021年   ■ 2022年   ■ 2023年
  ■ 2024年   ■ 2025年   ■   ■   ■   ■   ■   ■

■ Neuro-Tokushima achievements 2019

 

1 論文・著書など（アルファベット順または五十音順）
1A 英文
1A-a. 原著

  1. Fujita K, Matsubara T, Miyamoto R, Sumikura H, Takeuchi T, Maruyama Saladini K, Kawarai T, Nodera H, Udaka F, Kume K, Morino H, Kawakami H, Hasegawa M, Kaji R, Murayama S, Izumi Y. Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report. BMC Neurol 2019;19(1):168.

  2. Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA; RESILIENT Study Group. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol 2019;18(9):834-844.

  3. Imamura K, Izumi Y, Banno H, Uozumi R, Morita S, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Hanajima R, Oki R, Fujita K, Takahashi N, Ikeda T, Shimizu A, Morinaga A, Hirohashi T, Fujii Y, Takahashi R, Inoue H. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients. BMJ Open 2019;9(12):e033131.

  4. Kaji R. Global burden of neurological diseases highlights stroke. Nat Rev Neurol 2019;15(7):371-372.

  5. Kaji R, Imai T, Iwasaki Y, Okamoto K, Nakagawa M, Ohashi Y, Takase T, Hanada T, Shimizu H, Tashiro K, Kuzuhara S. Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study. J Neurol Neurosurg Psychiatry. 2019;90(4):451-457.

  6. Kawarai T, Orlacchio A, Kaji R. Lesser motor disability in adulthood: A ten-year follow-up of a dyskinetic patient with ADCY5 mutation. J Neurol Sci 2019;405:116383.

  7. Kawarai T, Yamazaki H, Miyamoto R, Takamatsu N, Mori A, Osaki Y, Orlacchio A, Nodera H, Hashiguchi A, Higuchi Y, Yoshimura A, Takashima H, Kaji R. PMP22-related disease: A novel splice site acceptor variant and intrafamilial phenotype variability. Neuromuscul Disord 2019;29(6):422-426.

  8. Kawarai T, Yamazaki H, Yamakami K, Tsukamoto-Miyashiro A, Kodama M, Rumore R, Caltagirone C, Nishino I, Orlacchio A. A novel AIFM1 missense mutation in a Japanese patient with ataxic sensory neuronopathy and hearing impairment. J Neurol Sci 2020;409:116584.

  9. Matsubara T, Oda M, Takahashi T, Watanabe C, Tachiyama Y, Morino H, Kawakami H, Kaji R, Maruyama H, Murayama S, Izumi Y. Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy. Neuropathology 2019;39(1):47-53.

  10. Murakami N, Sako W, Haji S, Furukawa T, Otomi Y, Otsuka H, Izumi Y, Harada M, Kaji R. Potential Utility of 123I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease. Front Neurol 2019;10:376.

  11. Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, Baba O, Kuwabara Y, Nishino T, Nakao T, Nishiga M, Nishi H, Nakashima Y, Ide Y, Koyama S, Kimura M, Tsuji S, Naitoh M, Suzuki S, Izumi Y, Kawarai T, Kaji R, Kimura T, Inoue H, Ono K. MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons. Clin Sci (Lond) 2019;133(4):583-595.

  12. Nodera H. Is it time to depart from dichotomization in ALS diagnosis? Clin Neurophysiol 2019;130(2):303-304.

  13. Nodera H, Osaki Y, Yamazaki H, Mori A, Izumi Y, Kaji R. Classification of needle-EMG resting potentials by machine learning. Muscle Nerve 2019;59(2):224-228.

  14. Nodera H, Osaki Y, Yamazaki H, Mori A, Izumi Y, Kaji R. Deep learning for waveform identification of resting needle electromyography signals. Clin Neurophysiol 2019;130(5):617-623.

  15. Nodera H, Sogawa K, Takamatsu N, Hashiguchi S, Saito M, Mori A, Osaki Y, Izumi Y, Kaji R. Texture analysis of sonographic muscle images can distinguish myopathic conditions. J Med Invest 2019;66(3.4):237-247.

  16. Sako W, Abe T, Furukawa T, Oki R, Haji S, Murakami N, Izumi Y, Harada M, Kaji R. Differences in the intra-cerebellar connections and graph theoretical measures between Parkinson's disease and multiple system atrophy. J Neurol Sci 2019;400:129-134.

  17. Sako W, Abe T, Haji S, Murakami N, Osaki Y, Izumi Y, Harada M, Kaji R. "One line": A method for differential diagnosis of parkinsonian syndromes. Acta Neurol Scand 2019;140(3):229-235.

  18. Sako W, Abe T, Izumi Y, Harada M, Kaji R. Deterministic-tractography-based approach for diagnosis and disease monitoring of amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2019;181:73-75.

  19. Shimizu F, Oishi M, Sawai S, Beppu M, Misawa S, Matsui N, Miyashiro A, Maeda T, Takeshita Y, Nishihara H, Sano Y, Sato R, Kaji R, Kuwabara S, Kanda T. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2019;90(4):444-450.

  20. Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Mori M, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Ito H, Higuchi I, Hashiguchi A, Nodera H, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M. The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan. Orphanet J Rare Dis 2019;14(1):155.

  21. Yamaguchi I, Kanematsu Y, Shimada K, Korai M, Miyamoto T, Shikata E, Yamaguchi T, Yamamoto N, Yamamoto Y, Kitazato KT, Okayama Y, Takagi Y. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke. Cerebrovasc Dis Extra 2019;9(3):129-138.

  22. Yamamoto N, Yamamoto Y, Yamaguchi I, Ishihara M, Miyamoto T, Korai M, Shimada K, Kanematsu Y, Izumi Y, Takagi Y. Cone beam-computed tomography angiography by intravenous contrast injection is reliable to evaluate patients with large vessel occlusion. J Clin Neurosci 2019;70:67-71.

  23. Yamamoto Y, Yamamoto N, Kanematsu Y, Korai M, Shimada K, Izumi Y, Takagi Y. The Claw Sign: An angiographic Predictor of Recanalization After Mechanical Thrombectomy for Cerebral Large Vessel Occlusion. J Stroke Cerebrovasc Dis 2019;28(6):1555-1560.